Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 20 10:29AM ET
29.61
Dollar change
-0.48
Percentage change
-1.58
%
IndexRUT P/E- EPS (ttm)-3.23 Insider Own7.89% Shs Outstand175.08M Perf Week3.91%
Market Cap5.54B Forward P/E- EPS next Y-2.90 Insider Trans-1.25% Shs Float172.36M Perf Month19.70%
Income-538.26M PEG- EPS next Q-1.01 Inst Own73.31% Short Float9.41% Perf Quarter-17.62%
Sales218.60M P/S25.35 EPS this Y18.79% Inst Trans2.41% Short Ratio9.85 Perf Half Y2.62%
Book/sh-5.61 P/B- EPS next Y9.69% ROA-72.98% Short Interest16.23M Perf Year111.84%
Cash/sh2.78 P/C10.66 EPS next 5Y- ROE- 52W Range12.75 - 44.32 Perf YTD-26.64%
Dividend Est.- P/FCF- EPS past 5Y-13.29% ROI-79.78% 52W High-33.18% Beta1.10
Dividend TTM- Quick Ratio5.54 Sales past 5Y117.77% Gross Margin96.50% 52W Low132.27% ATR (14)1.23
Dividend Ex-Date- Current Ratio5.54 EPS Y/Y TTM-13.87% Oper. Margin-216.34% RSI (14)58.39 Volatility3.92% 4.35%
Employees550 Debt/Eq- Sales Y/Y TTM181.05% Profit Margin-246.23% Recom1.23 Target Price50.17
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q78.53% Payout- Rel Volume0.35 Prev Close30.09
Sales Surprise2808.19% EPS Surprise72.86% Sales Q/Q11461.88% EarningsMay 02 BMO Avg Volume1.65M Price29.61
SMA208.00% SMA506.40% SMA200-3.23% Trades Volume112,342 Change-1.58%
Date Action Analyst Rating Change Price Target Change
Mar-21-24Resumed Raymond James Outperform $45
Jan-31-24Initiated BMO Capital Markets Market Perform $37
Dec-08-23Initiated Wells Fargo Overweight $58
Dec-08-23Initiated Wells Fargo Overweight
Nov-07-23Initiated Citigroup Buy $42
Oct-24-23Initiated Cantor Fitzgerald Overweight $50
Jul-18-23Downgrade Jefferies Buy → Hold $24 → $33
Apr-19-23Initiated Evercore ISI Outperform $40
Feb-06-23Initiated Cowen Outperform
Dec-27-21Reiterated SVB Leerink Outperform $66 → $24
May-15-24 07:30AM
May-14-24 07:30AM
May-13-24 07:30AM
May-03-24 06:22AM
May-02-24 10:55PM
10:27AM Loading…
10:27AM
07:40AM
07:30AM
07:00AM
03:00AM
May-01-24 08:10AM
Apr-25-24 10:02AM
Apr-10-24 07:30AM
Apr-07-24 01:15PM
Mar-27-24 09:25AM
07:30AM Loading…
Mar-20-24 07:30AM
Mar-05-24 11:53PM
Mar-04-24 04:17PM
04:05PM
03:00AM
02:30AM
02:30AM
02:30AM
Feb-22-24 08:40AM
07:53AM
07:52AM
07:30AM
Feb-15-24 10:00AM
06:54AM
Feb-07-24 07:34AM
07:22AM Loading…
07:22AM
Feb-06-24 07:30AM
Feb-05-24 07:30AM
Feb-02-24 07:00AM
Jan-30-24 07:00AM
Jan-29-24 12:35PM
Jan-18-24 07:59PM
07:00AM
06:21AM
Jan-12-24 09:23AM
Jan-10-24 05:15PM
07:30AM
Jan-03-24 04:30PM
07:30AM
06:45AM
Dec-28-23 12:20PM
Dec-26-23 06:56PM
Dec-18-23 05:34AM
Dec-13-23 07:30AM
Dec-08-23 07:30AM
Dec-05-23 01:34PM
07:44AM
Nov-21-23 05:03PM
Nov-12-23 10:30AM
Nov-09-23 07:30AM
Nov-08-23 07:30AM
Nov-02-23 09:21AM
07:45AM
07:30AM
Oct-26-23 10:02AM
Oct-24-23 07:57PM
Oct-20-23 01:22PM
Oct-11-23 07:30AM
Oct-10-23 07:30AM
Oct-09-23 07:30AM
Oct-03-23 07:31AM
Sep-25-23 07:30AM
Sep-13-23 08:08AM
Sep-08-23 07:30AM
Sep-07-23 07:30AM
Sep-06-23 07:30AM
Aug-28-23 04:06PM
10:00AM
Aug-27-23 06:15AM
Aug-24-23 04:01PM
Aug-16-23 06:35AM
Aug-14-23 06:01PM
Aug-09-23 10:07AM
Aug-04-23 07:30AM
07:28AM
Aug-03-23 09:05AM
07:57AM
07:30AM
Jul-31-23 07:30AM
06:13AM
Jul-21-23 10:44AM
10:11AM
Jul-18-23 11:25AM
09:53AM
09:16AM
07:30AM
Jul-17-23 08:40PM
04:07PM
02:21PM
12:29PM
12:25PM
11:55AM
10:37AM
10:13AM
10:01AM
BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Frank McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Scott Randal W.DirectorMar 01 '24Sale34.002,50085,0006,500Mar 05 04:00 PM
Valantine HannahDirectorFeb 15 '24Option Exercise8.452,91524,6324,679Feb 20 04:03 PM
Valantine HannahDirectorFeb 15 '24Sale37.752,915110,0411,764Feb 20 04:03 PM
Valantine HannahDirectorJan 16 '24Option Exercise8.452,91524,6324,679Jan 18 04:10 PM
Valantine HannahDirectorJan 16 '24Sale37.972,915110,6831,764Jan 18 04:10 PM
MCCORMICK FRANKDirectorDec 26 '23Sale42.06100,0004,206,000627,689Dec 28 04:00 PM
Scott Randal W.DirectorDec 18 '23Sale40.002,00080,0009,000Dec 20 04:00 PM
Valantine HannahDirectorDec 15 '23Option Exercise8.452,91524,6324,679Dec 19 04:00 PM
Valantine HannahDirectorDec 15 '23Sale36.122,915105,2901,764Dec 19 04:00 PM
Scott Randal W.DirectorDec 01 '23Sale29.402,50073,50011,000Dec 05 04:00 PM
Kumar NeilCEO and PresidentNov 17 '23Sale29.1051,5521,500,0384,813,197Nov 20 04:00 PM
STEPHENSON BRIAN CSecretary, Treasurer & CFONov 17 '23Sale29.1022,685660,05936,710Nov 20 04:00 PM
Valantine HannahDirectorNov 15 '23Option Exercise8.452,91524,6324,679Nov 17 04:09 PM
Valantine HannahDirectorNov 15 '23Sale30.002,91587,4501,764Nov 17 04:09 PM
Scott Randal W.DirectorSep 05 '23Sale30.002,50075,00013,500Sep 07 04:00 PM
Kumar NeilCEO and PresidentAug 17 '23Sale28.5951,5521,473,7844,813,197Aug 18 04:00 PM
STEPHENSON BRIAN CSecretary, Treasurer & CFOAug 17 '23Sale28.5922,683648,45536,710Aug 18 04:00 PM
VIKING GLOBAL INVESTORS LP10% OwnerJul 18 '23Sale35.001,500,00052,500,00025,120,991Jul 19 09:33 PM